NCT03034044View on ClinicalTrials.gov

Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 17, 2018

Study Completion Date

January 17, 2018

Conditions
Factor VIII Deficiency, CongenitalFactor 8 Deficiency, CongenitalAutosomal Hemophilia AClassic HemophiliaHemophilia A, Congenital
Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03034044 - Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe | Biotech Hunter | Biotech Hunter